BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15919723)

  • 1. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription.
    Ellison TI; Dowd DR; MacDonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2309-19. PubMed ID: 15919723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1.
    Gill RK; Atkins LM; Hollis BW; Bell NH
    Mol Endocrinol; 1998 Jan; 12(1):57-65. PubMed ID: 9440810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
    Sutton AL; Zhang X; Ellison TI; Macdonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
    Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
    Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of thyroid hormone receptor-mediated transcription by Ca2+/calmodulin-dependent protein kinase type IV.
    Kuno-Murata M; Koibuchi N; Fukuda H; Murata M; Chin WW
    Endocrinology; 2000 Jun; 141(6):2275-8. PubMed ID: 10830318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
    Liu YY; Nguyen C; Peleg S
    Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
    Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
    J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation.
    Oda Y; Sihlbom C; Chalkley RJ; Huang L; Rachez C; Chang CP; Burlingame AL; Freedman LP; Bikle DD
    Mol Endocrinol; 2003 Nov; 17(11):2329-39. PubMed ID: 12893881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; HenrĂ­quez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
    Solomon C; Macoritto M; Gao XL; White JH; Kremer R
    J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.